Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.320
-0.150 (-6.07%)
At close: Feb 21, 2025, 4:00 PM
2.280
-0.040 (-1.72%)
After-hours: Feb 21, 2025, 7:32 PM EST
Zentalis Pharmaceuticals Employees
Zentalis Pharmaceuticals had 124 employees as of December 31, 2023. The number of employees decreased by 32 or -20.51% compared to the previous year.
Employees
124
Change (1Y)
-32
Growth (1Y)
-20.51%
Revenue / Employee
$327,097
Profits / Employee
-$1,445,839
Market Cap
165.34M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 124 | -32 | -20.51% |
Dec 31, 2022 | 156 | -21 | -11.86% |
Dec 31, 2021 | 177 | 53 | 42.74% |
Dec 31, 2020 | 124 | 62 | 100.00% |
Dec 31, 2019 | 62 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ZNTL News
- 18 days ago - Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 24 days ago - Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer - GlobeNewsWire
- 24 days ago - Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development - GlobeNewsWire
- 6 weeks ago - Zentalis Pharmaceuticals Announces Azenosertib Fast Track Designation and Virtual Corporate Event to Present Updated Data from Azenosertib Clinical Studies - GlobeNewsWire
- 7 weeks ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Zentalis Pharmaceuticals Announces Key Management Appointments - GlobeNewsWire
- 3 months ago - Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm - GlobeNewsWire
- 4 months ago - FMR LLC Adjusts Its Stake in Zentalis Pharmaceuticals Inc - GuruFocus